Estimated direct costs of non-small cell lung cancer by stage at diagnosis and disease management phase: A whole-disease model.

Thoracic Cancer
Alessandra BujaPierFranco Conte

Abstract

Non-small cell lung cancer (NSCLC) is the first cause of cancer-related death among men and the second among women worldwide. It also poses an economic threat to the sustainability of healthcare services. This study estimated the direct costs of care for patients with NSCLC by stage at diagnosis, and management phase of pathway recommended in local and international guidelines. Based on the most up-to-date guidelines, we developed a very detailed "whole-disease" model listing the probabilities of all potentially necessary diagnostic and therapeutic actions involved in the management of each stage of NSCLC. We assigned a cost to each procedure, and obtained an estimate of the total and average per-patient costs of each stage of the disease and phase of its management. The mean expected cost of a patient with NSCLC is 21,328 € (95% C.I. -20 897-22 322). This cost is 16 291 € in stage I, 19530 € in stage II, 21938 € in stage III, 22175 € in stage IV, and 28 711 € for a Pancoast tumor. In the early stages of the disease, the main cost is incurred by surgery, whereas in the more advanced stages radiotherapy, medical therapy, treatment for progressions, and supportive care become variously more important. An estimation of the direct ...Continue Reading

References

May 2, 2006·International Journal of Radiation Oncology, Biology, Physics·Feng-Ming KongRandall K Ten Haken
Apr 25, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Alex G LittleAndrew K Stewart
Dec 3, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Daniel MorgenszternRamaswamy Govindan
Nov 6, 2010·Journal of Cardiothoracic Surgery·Haralabos Parissis, Vincent Young
Jan 8, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Lauren E CiprianoPamela M McMahon
May 24, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Shalini K VinodNevin Murray
Jun 21, 2012·The Journal of Thoracic and Cardiovascular Surgery·Maria Teresa CongedoPierluigi Granone
Dec 19, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Paul TappendenMatthew Stevenson
Jan 23, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Angela Ihbe-HeffingerC Peschel
Nov 22, 2014·Practical Radiation Oncology·Mark R WaddleLawrence B Marks
Dec 4, 2014·The New England Journal of Medicine·Benjamin J SolomonUNKNOWN PROFILE 1014 Investigators
Apr 19, 2015·BMC Health Services Research·Julieta CorralJosep Maria Borràs
Aug 27, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Pricivel M Carrera, Ian Olver
Sep 20, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Larissa SchwarzkopfRudolf Maria Huber
Nov 22, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·N van der LindenC A Uyl-de Groot
Dec 17, 2015·Advances in Experimental Medicine and Biology·Lindsey A TorreAhmedin Jemal
Feb 9, 2016·International Journal of Radiation Oncology, Biology, Physics·Luca F ValleNirav S Kapadia
May 1, 2016·Preventive Medicine·Muhammad Usman AliParminder Raina
Oct 11, 2016·The New England Journal of Medicine·Martin ReckUNKNOWN KEYNOTE-024 Investigators
Feb 18, 2017·Lung Cancer : Targets and Therapy·Sarah Baker, Alysa Fairchild
Apr 14, 2017·Journal of Surgical Oncology·Ryuichi WasedaWalter Klepetko
May 4, 2017·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Kari ChanskyUNKNOWN IASLC Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions
Jun 7, 2017·The New England Journal of Medicine·Solange PetersUNKNOWN ALEX Trial Investigators
Jun 20, 2017·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Elisabeth J DriessenMaryska L Janssen-Heijnen
Jun 27, 2017·The Annals of Thoracic Surgery·Zhiqiang XueShanda Blackmon
Jul 8, 2017·Seminars in Thoracic and Cardiovascular Surgery·Piergiorgio SolliLorenzo Spaggiari
Sep 9, 2017·The New England Journal of Medicine·Scott J AntoniaUNKNOWN PACIFIC Investigators
Oct 13, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leora HornWilfried E E Eberhardt
Nov 7, 2017·The Annals of Thoracic Surgery·Nirav S KapadiaFeng Ming Kong
Nov 16, 2017·Future Oncology·Laura Mezquita, David Planchard
Nov 21, 2017·The New England Journal of Medicine·Jean-Charles SoriaUNKNOWN FLAURA Investigators
Dec 7, 2017·The Lancet Oncology·Matthijs OudkerkJohn K Field
Apr 17, 2018·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Luis E RaezOscar Arrieta
Dec 24, 2018·Cancer Medicine·Deirdre F SheehanChung Yin Kong

❮ Previous
Next ❯

Citations

Apr 8, 2021·JCO Oncology Practice·Alessandra BujaPierFranco Conte

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.